Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group

Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group

Endometrial carcinoma (EC) is the most common gynecological malignant disease in high-income countries, such as European countries and the USA. The 2020 edition of the World Health Organization (WHO) Classification of Tumors of the Female Genital Tract underlines the important clinical implications...

Full description

Bibliographic Details
Main Authors:	Gian Franco Zannoni, Emma Bragantini, Francesca Castiglione, Matteo Fassan, Giancarlo Troncone, Frediano Inzani, Anna Pesci, Angela Santoro, Filippo Fraggetta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Oncology
Subjects:	endometrial cancer prognostic markers histomolecular classification pathological guidelines prognostic stratification
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.805613/full

Similar Items

Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer
by: Giulia Scaglione, et al.
Published: (2023-10-01)

Independent prognostic factors in endometrial cancer: a single institution review
by: Uharček P., et al.
Published: (2011-06-01)

Clinical characteristics of postmenopausal women with endometrial polyps
by: E. G. Kobaidze, et al.
Published: (2022-07-01)

Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes
by: Giuseppe Angelico, et al.
Published: (2020-08-01)

The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
by: Anže Feguš, et al.
Published: (2024-09-01)

Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network
by: Ming-Jun Zheng, et al.
Published: (2018-12-01)

Hematologic inflammatory indexes as a prognostic factor in endometrial cancer grading and staging
by: Mahdiss Mohamadianamiri, et al.
Published: (2023-05-01)

Development of a disulfidptosis-related prognostic model for endometrial cancer with potential therapeutic target
by: Chunmei Li, et al.
Published: (2024-10-01)

Determinants of Response at 2 Months of Treatment in a Cohort of Pakistani Patients with Pulmonary Tuberculosis
by: Saeed Shah, et al.
Published: (2022-09-01)

Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer
by: Zi-Hao Wang, et al.
Published: (2019-11-01)

Routine digital pathology workflow: The Catania experience
by: Filippo Fraggetta, et al.
Published: (2017-01-01)

Evaluation of Tissue Expression of Vaspin and Serum Vaspin Concentration as a Prognostic and Risk Factor in Endometrial Cancer
by: Mateusz Kozłowski, et al.
Published: (2022-10-01)

Identification and validation of glucose metabolism-related gene signature in endometrial cancer
by: Juan Jiang, et al.
Published: (2025-01-01)

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-08-01)

Treatment Outcomes of Advanced Stage Endometrial Carcinoma (Stage III-IV) and Related Factors
by: Jesada Wutitammasuk, et al.
Published: (2020-01-01)

Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma
by: Junfeng Chen, et al.
Published: (2022-12-01)

Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01)

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
by: Jinhui Liu, et al.
Published: (2020-07-01)

Exploring the Prognostic and Predictive Roles of Ki-67 in Endometrial Cancer
by: Laura Paleari, et al.
Published: (2023-11-01)

Identification of genetic and immune mechanisms linking preeclampsia and endometrial cancer: a prognostic model for survival and treatment response
by: Fei Teng, et al.
Published: (2024-11-01)

Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma
by: Jinhui Liu, et al.
Published: (2021-01-01)

Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
by: Kohei Fukuoka, et al.
Published: (2023-09-01)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
by: Simona Giglio, et al.
Published: (2019-06-01)

FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
by: Dae Hyun Song, et al.
Published: (2023-12-01)

Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
by: Ju-Hyun Kim, et al.
Published: (2022-05-01)

Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma
by: Mianxin Chew, et al.
Published: (2020-06-01)

Tumor‐infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape
by: Liping Zhang, et al.
Published: (2024-01-01)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
by: Xiao Yang, et al.
Published: (2022-02-01)

A comparison of 2D and 3D magnetic resonance imaging-based intratumoral and peritumoral radiomics models for the prognostic prediction of endometrial cancer: a pilot study
by: Ruixin Yan, et al.
Published: (2024-07-01)

Prognostication of Breast Cancer in Ghanaian Women Receiving Modified Radical Mastectomy: A Retrospective Histopathological Study at Korle-Bu Teaching Hospital, Accra, Ghana
by: Edmund Muonir Der, et al.
Published: (2018-08-01)

Pyroptosis-associated genes and tumor immune response in endometrial cancer
by: Xiaodi Gong, et al.
Published: (2024-09-01)

Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights
by: Jie Liu, et al.
Published: (2024-03-01)

Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer
by: Jianchao Ying, et al.
Published: (2018-05-01)

Elevation of circulating neutrophil extracellular traps in endometrial cancer: Poor prognostic value of cell-free double-stranded DNA
by: Yeonju Seo, et al.
Published: (2024-11-01)

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
by: Jinzhi Lai, et al.
Published: (2022-03-01)

An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls
by: Giuseppe Angelico, et al.
Published: (2021-04-01)

The prognostic role of mitosis index, stage and grade of endometrial cancer in Dr. Soetomo General Academic Hospital Surabaya, Indonesia, in 2018-2020
by: Farida Umi Choviva, et al.
Published: (2024-07-01)

The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer
by: Wenzhe Li, et al.
Published: (2024-10-01)

Identification of an Immune Cell Infiltration-Related Prognostic Model to Guide Immunotherapy in Endometrial Carcinoma
by: Haijun Zhu, et al.
Published: (2023-10-01)

Fatty acid metabolism-related signature suggests an oncogenic role of TEKT1 in endometrial cancer
by: Zhikai Xiahou, et al.
Published: (2025-01-01)